Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a

Clinical Cancer Research

Volumn 17, Issue 10, 2011, Pages 3089-3099

  Lin, Chuyong ^a,b   Wu, Zhiqiang ^a,b   Lin, Xi ^a   Yu, Chunping ^a   Shi, Tingting ^c   Zeng, Yong ^a   Wang, Xi ^a   Li, Jun ^b   Song, Libing ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Guangzhou International Business Incubator D   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; FLOTILLIN 1; LUCIFERASE; PARAFFIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE REGULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; RNA, SMALL INTERFERING; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79956033520     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-3068     Document Type: Article

References (33)

1. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science 2010;327:46-50.
2. Jacobson K, Mouritsen OG, Anderson RG. Lipid rafts: at a crossroad between cell biology and physics. Nat Cell Biol 2007;9:7-14. (Pubitemid 46024188)
3. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000;1:31-39.
4. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569-72. (Pubitemid 27248754)
5. Patra SK. Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 2008;1785:182-206.
6. Patra SK, Bettuzzi S. Epigenetic DNA-methylation regulation of genes coding for lipid raft-associated components: a role for raft proteins in cell transformation and cancer progression. Oncol Rep 2007;17:1279-90.
7. Mollinedo F, de la, Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, Campanero MA, et al. Lipid raft-targeted therapy in multiple myeloma. Oncogene 2010;29:3748-57.
8. Hitosugi T, Sato M, Sasaki K, Umezawa Y. Lipid raft specific knockdown of SRC family kinase activity inhibits cell adhesion and cell cycle progression of breast cancer cells. Cancer Res 2007;67:8139-48. (Pubitemid 47395149)
9. Bickel PE, Scherer PE, Schnitzer JE, Oh P, Lisanti MP, Lodish HF. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J Biol Chem 1997;272:13793-802. (Pubitemid 27225457)
10. Babuke T, Tikkanen R. Dissecting the molecular function of reggie/flotillin proteins, Eur. J Cell Biol 2007;86:525-32. (Pubitemid 47233374)
11. Langhorst MF, Reuter A, Stuermer CA. Scaffolding microdomains and beyond: the function of reggie/flotillin proteins. Cell Mol Life Sci 2005;62:2228-40. (Pubitemid 41500540)
12. Riento K, Frick M, Schafer I, Nichols BJ. Endocytosis of flotillin-1 and flotillin-2 is regulated by Fyn kinase. J Cell Sci 2009;122:912-8.
13. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, et al. CAP defines a second signaling pathway required for insulin-stimulated glucose transport. Nature 2000;407:202-7.
14. Limpert AS, Karlo JC, Landreth GE. Nerve growth factor stimulates the concentration of TrkA within lipid rafts and extracellular signal-regulated kinase activation through c-Cbl-associated protein. Mol Cell Biol 2007;27:5686-98. (Pubitemid 47257826)
15. Santamaría A, Castellanos E, Gómez V, Benedit P, Renau-Piqueras J, Morote J, et al. PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts. Mol Cell Biol 2005;25:1900-11. (Pubitemid 40280153)
16. Gómez V, Sesé M, Santamaría A, Martínez JD, Castellanos E, Soler M, et al. Regulation of aurora B kinase by the lipid raft protein flotillin-1. J Biol Chem 2010;285:20683-90.
17. Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY, et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 2008;14:3319-26.
18. Tang ED, Nunez G, Barr FG, Guan KL, et al. Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 1999;274:16741-6.
19. Greene FLPD, Fleming ID. Breast cancer in AJCC Cancer Stage Handbook. TNM Classification of Malignant Tumors. 6th ed. New York: Springer Verlag, 2002.
20. Simpson JF, Gray R, Dressler LG, Cobau CD, Falkson CI, Gilchrist KW, et al. Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin Oncol 2000;18:2059-69. (Pubitemid 30324359)
21. Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci 2007;120:2479-87. (Pubitemid 47323857)
22. Doerfler W, Hohlweg U, Müller K, Remus R, Heller H, Hertz J. Foreign DNA integration perturbations of the genome-oncogenesis. Ann N Y Acad Sci 2001;945:276-88. (Pubitemid 33022464)
23. Nemoto S, Fergusson MM, Finkel T.Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 2004;306:2105-8. (Pubitemid 40007664)
24. Yiyu Zou, Wen-Bin Tsai, Chien-Jui Cheng, Hsu C, Chung YM, Li PC, et al. Forkhead box transcription factor FOXO3a suppresses estrogen- dependent breast cancer cell proliferation and tumorigenesis. Breast Cancer Research 2008;10:R21-34.
25. Real PJ, Benito A, Cuevas J, Berciano MT, de Juan A, Coffer P, et al. Blockade of epidermal growth factor receptors chemosensitizes breast cancer cells through up-regulation of Bnip3L. Cancer Res 2005;65:8151-7. (Pubitemid 41330578)
26. Sunters A, Fernández de Mattos S, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA, et al. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 2003;278:49795-805. (Pubitemid 37548813)
27. Yang JY, Chang CJ, Xia W, Wang Y, Wong KK, Engelman JA, et al. Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer. Cancer Res 2010;70:4709-18.
28. Hu M, Lee C, Xia DF, Golfman LS, Ou-Yang F, Yang JY, et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004;117:225-37. (Pubitemid 38496242)
29. Zhuang L, Lin J, Lu ML, Solomon KR, Freeman MR. Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells. Cancer Res 2002;62:2227-31.
30. Pommier AJ, Alves G, Viennois E, Bernard S, Communal Y, Sion B, et al. Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene 2010;29:2712-23.
31. Bellyei S, Szigeti A, Boronkai A, Pozsgai E, Gomori E, Melegh B, et al. Inhibition of cell death by a novel 16.2 kD heat shock protein predominantly via Hsp90 mediated lipid rafts stabilization and Akt activation pathway. Apoptosis 2007;12:97-112. (Pubitemid 46009507)
32. Zhuang L, Kim J, Adam RM, Solomon KR, Freeman MR. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 2005;115:959-68. (Pubitemid 40489400)
33. Calay D, Vind-Kezunovic D, Frankart A, Lambert S, Poumay Y, Gniadecki R. Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes. J Invest Dermatol 2010;130:1136-45.